Through bioinformatics analysis, we observed the enriched MEOX2 occupation of gene promoter sequences (Log2 above 532 nm fluorescence) versus RNA Pol II occupation (Log2 below 635 nm fluorescence) in the lung cancer patients designated P-13, P-6 and P-3 (Figure 1A). This evidence concerns the gene MEOX2 and lung carcinoma.